Table 5.
Ref.
|
Study
|
Volume
|
Jeremic et al[41] 1999 | Prospective, randomised | GTV + hilum + 2 cm; entire mediastinum + both supraclavicular fossae + 1 cm |
Zhu et al[116] 2011 | Retrospective | Primary GTV + GTVn > 1 cm short axis |
Yee et al[117] 2012 | Prospective, phase II | GTVp + GTVn visible on planning CT |
Slotman et al[44] 2015 | Phase III, randomised | GTVp post-CT + 15 mm + ipsilateral hilum + nodes involved pre-CT |
Luan et al[119] 2015 | Retrospective | CR post-CT: Primary GTV bed and GTVn involved pre-CT; SD post-CT: GTVp + GTVn; PD post-CT: New GTVp + GTVn + GTV |
Qin et al[118] 2016 | Retrospective | GTV: Thoracic, mediastinal, and supraclavicular fossae |
Gore et al[47] 2017 | Phase II, randomised | Post-CT volume including the primary tumour and nodal areas involved at diagnosis |
Luo et al[120] 2017 | Retrospective | Post-CT GTVp + pre-CT primary tumour bed + GTVn of nodes involved pre-CT |
Zhang et al[121] 2017 | Literature review | CR: Mediastinum initially involved; PR: Residual pulmonary lesions + initially involved lymph nodes |
GTV: Gross tumour volume; GTVn: Lymph node gross tumour volume; GTVp: Primary gross tumour volume; CT: Computed tomography; CR: Complete response; PR: Partial response; SD: Stable disease; PD: Progressive disease.